MRC Laboratory of Molecular Biology
One of the world's leading research institutes, our scientists are working to advance understanding of biological processes at the molecular level - providing the knowledge needed to solve key problems in human health.
On Monday 25th November 2013, the LMB will be hosting a Women in Science Wikipedia Edit-a-thon – the latest in a series of such events to celebrate the MRC’s Centenary.
The event is based on the Edit-a-thon held in 2012 on Ada Lovelace Day, a day which celebrates the achievements of women in science, technology, engineering and maths (STEM).
Michael Neuberger, Deputy Director of the LMB and Head of Division of Protein and Nucleic Acid Chemistry died on Saturday 26 October, after several months of serious illness. He was an outstanding and brilliant scientist.
Michael was educated at Westminster School and Trinity College Cambridge, received a first class honours degree in Natural Sciences (Biochemistry), and started a PhD in Biochemistry with Brian Hartley at Imperial College in London in 1974.
Joan Steitz will give the John Kendrew Lecture 2013 on Friday 1st November at 4.15pm in the LMB’s Max Perutz Lecture Theatre. The title of the lecture is ‘Non-coding RNAs: with a viral twist.’ This event is open to anyone in the local area who is interested in attending.
Joan Steitz is interested in the multiple roles played by non-coding RNA–protein complexes in gene expression in vertebrate cells.
The LMB is delighted to congratulate Michael Levitt, Arieh Warshel and Martin Karplus on being awarded the 2013 Nobel Prize in Chemistry, for the development of multiscale models for complex chemical systems.
A key part of the Nobel Prize winning research was undertaken at the LMB, in the Structural Studies Division, in the 1970s by Michael Levitt in collaboration with Arieh Warshel.
Professor Scott Emr will give the 2013 Milstein Lecture on Thursday 26 September at 4.15pm in the LMB’s Max Perutz Lecture Theatre. The lecture, entitled “Sorting out protein traffic: Ubiquitin-mediated endocytosis and a membrane protein’s final ESCRT”, is open to anyone in the local area who is interested in attending.
Scott is currently Professor of Molecular Biology and Genetics, and Director of the Weill Institute for Cell and Molecular Biology, at Cornell University.
A method for parallel assembly of a large number of peptide-therapeutic cargo combinations, developed by Mike Gait’s group in the LMB’s PNAC Division, has been licensed to Cambridge Research Biochemicals (CRB). The company aims to launch a service in October to provide both researchers and pharmaceutical companies with custom-made libraries of peptide-cargo conjugates to help accelerate the delivery and development of new therapeutics.